Anzeige
Mehr »
Donnerstag, 05.06.2025 - Börsentäglich über 12.000 News
Neuer Top-Geologe an Bord - zündet jetzt die nächste Kursrakete?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 883035 | ISIN: US8816242098 | Ticker-Symbol: TEV
Tradegate
04.06.25 | 19:55
15,350 Euro
-0,32 % -0,050
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
TEVA PHARMACEUTICAL INDUSTRIES LTD Chart 1 Jahr
5-Tage-Chart
TEVA PHARMACEUTICAL INDUSTRIES LTD 5-Tage-Chart
RealtimeGeldBriefZeit
15,35015,45004.06.
15,20015,50004.06.

Aktuelle News zur TEVA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiTeva bei Jefferies Healthcare: Strategisches Wachstum und Innovation9
MiTeva Pharmaceutical prices and manages debt24
DiTeva Pharmaceutical Industries Ltd: Teva Announces Pricing and Early Acceptance Results of its Debt Tender Offer326TEL AVIV, Israel, June 03, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) ("Teva") announced today the pricing and early acceptance results of its previously announced...
► Artikel lesen
DiTeva Pharmaceutical Industries Ltd: Teva Announces Early Tender Results of its Debt Tender Offer, Increase to Tender Pool Caps and Total Maximum Amount and Election of Early Settlement320TEL AVIV, Israel, June 03, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) ("Teva") announced today the early tender results in connection with its previously announced...
► Artikel lesen
SaTeva Study Highlights Gaps In Tardive Dyskinesia Diagnosis And Treatment In LTC Facilities644PETAH TIKVA (dpa-AFX) - Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (TEVA), announced results from a study of treatment patterns among patients with tardive...
► Artikel lesen
SaTeva Pharmaceutical Industries Ltd: Teva Presents Latest Schizophrenia Portfolio Data Including Real-World Outcomes with UZEDY (risperidone) Showing Lower Rates of and Longer Time to Relapse Compared to Oral Treatment Options and New Phase 3 SOLARIS Data520Real-world claims studies evaluating UZEDY® (risperidone) also show improved adherence and persistence rates, fewer inpatient, outpatient and emergency department (ED) visits versus second-generation...
► Artikel lesen
SaTeva Pharmaceutical Industries Ltd: New Data from Teva Shows Substantial Rates of Undertreated Tardive Dyskinesia in Long-Term Care Settings at Psych Congress Elevate 2025501More than half of residents with tardive dyskinesia (TD) residing in long-term care (LTC) settings do not receive standard of care treatment, and one-quarter are left untreatedLTC residents are often...
► Artikel lesen
TEVA Aktie jetzt für 0€ handeln
29.05.Teva Reaffirms Growth Strategy, Eyes $5 Billion Innovative Franchise By 203030
29.05.Teva gives aggressive guidance for innovative drugs32
29.05.Teva Reaffirms 2027 Financial Targets380PETAH TIKVA (dpa-AFX) - Teva Pharmaceutical Industries Ltd. (TEVA) reaffirmed 2027 financial targets, including 30% operating profit margin, driven by growth and transformation programs. The...
► Artikel lesen
29.05.Teva maintains 2027 financial goals, eyes 30% operating profit margin8
29.05.Teva Pharmaceutical Industries Ltd: Teva Reaffirms "Pivot to Growth" Strategy Progress with Launch of Acceleration Phase at 2025 Innovation and Strategy Day381Teva outlines acceleration path into a leading biopharma companyInnovative medicines franchise on track to exceed $5 billion by 2030, led by AUSTEDO® (deutetrabenazine), AJOVY® (fremanezumab), UZEDY®...
► Artikel lesen
28.05.Where Teva Pharmaceutical Indus Stands With Analysts11
28.05.Teva wins new Buy at Truist ahead of Innovation & Strategy Day14
28.05.TEVA Begins IND-Enabling Studies on Inflammatory Disease Candidate10
28.05.FDA fast-tracks Teva's coeliac disease treatment10
28.05.Teva Gets FDA Fast Track Designation For Investigational Celiac Disease Drug TEV-53408397PETAH TIKVA (dpa-AFX) - Teva Pharmaceutical Industries Ltd. (TEVA) announced that the US Food and Drug Administration granted Fast Track designation for investigational TEV-53408, an anti-IL-15...
► Artikel lesen
28.05.Teva Pharmaceutical Industries Limited (TEVA) Wins FDA Fast Track for Celiac Disease Drug TEV-5340821
27.05.Teva Pharmaceutical Industries Ltd: Teva Celiac Disease Candidate Granted Fast Track Designation by US FDA754Fast Track designation granted for investigational TEV-53408, an anti-IL-15 antibodyDesignation underscores the potential of TEV-53408, currently undergoing a Phase 2a study for the treatment of celiac...
► Artikel lesen
27.05.Truist starts Teva Pharma coverage with Buy, sets $25 target12
Seite:  Weiter >>
307 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
2,1,2